384 related articles for article (PubMed ID: 16836950)
1. Current gut-directed therapies for irritable bowel syndrome.
Chang HY; Kelly EC; Lembo AJ
Curr Treat Options Gastroenterol; 2006 Jul; 9(4):314-23. PubMed ID: 16836950
[TBL] [Abstract][Full Text] [Related]
2. Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2007 Oct; (4):CD003960. PubMed ID: 17943807
[TBL] [Abstract][Full Text] [Related]
3. Treatment of irritable bowel syndrome.
Trinkley KE; Nahata MC
J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
[TBL] [Abstract][Full Text] [Related]
4. Novel Therapies in IBS-D Treatment.
Nee J; Zakari M; Lembo AJ
Curr Treat Options Gastroenterol; 2015 Dec; 13(4):432-40. PubMed ID: 26432092
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome.
Camilleri M; Chey WY; Mayer EA; Northcutt AR; Heath A; Dukes GE; McSorley D; Mangel AM
Arch Intern Med; 2001 Jul; 161(14):1733-40. PubMed ID: 11485506
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.
Chey WD; Maneerattaporn M; Saad R
Gut Liver; 2011 Sep; 5(3):253-66. PubMed ID: 21927652
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
8. Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS.
Lacy BE
Neurogastroenterol Motil; 2016 Jan; 28(1):26-35. PubMed ID: 26690872
[TBL] [Abstract][Full Text] [Related]
9. Tegaserod for the treatment of irritable bowel syndrome.
Evans BW; Clark WK; Moore DJ; Whorwell PJ
Cochrane Database Syst Rev; 2004; (1):CD003960. PubMed ID: 14974049
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of IBS in adults.
Wilkins T; Pepitone C; Alex B; Schade RR
Am Fam Physician; 2012 Sep; 86(5):419-26. PubMed ID: 22963061
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.
Tack J; Müller-Lissner S; Bytzer P; Corinaldesi R; Chang L; Viegas A; Schnekenbuehl S; Dunger-Baldauf C; Rueegg P
Gut; 2005 Dec; 54(12):1707-13. PubMed ID: 16020489
[TBL] [Abstract][Full Text] [Related]
12. Drug therapy options for patients with irritable bowel syndrome.
Talley NJ
Am J Manag Care; 2001 Jul; 7(8 Suppl):S261-7. PubMed ID: 11474911
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies for diarrhea-predominant irritable bowel syndrome.
Olden KW
Clin Exp Gastroenterol; 2012; 5():69-100. PubMed ID: 22754282
[TBL] [Abstract][Full Text] [Related]
14. Rifaximin and eluxadoline - newly approved treatments for diarrhea-predominant irritable bowel syndrome: what is their role in clinical practice alongside alosetron?
Cash BD; Lacy BE; Rao T; Earnest DL
Expert Opin Pharmacother; 2016; 17(3):311-22. PubMed ID: 26559529
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Irritable Bowel Syndrome.
Spiller RC
Curr Treat Options Gastroenterol; 2003 Aug; 6(4):329-337. PubMed ID: 12846942
[TBL] [Abstract][Full Text] [Related]
16. A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.
Chang L; Ameen VZ; Dukes GE; McSorley DJ; Carter EG; Mayer EA
Am J Gastroenterol; 2005 Jan; 100(1):115-23. PubMed ID: 15654790
[TBL] [Abstract][Full Text] [Related]
17. Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.
Rivkin A; Rybalov S
Pharmacotherapy; 2016 Mar; 36(3):300-16. PubMed ID: 26971716
[TBL] [Abstract][Full Text] [Related]
18. The risk of ischaemic colitis in irritable bowel syndrome patients treated with serotonergic therapies.
Lewis JH
Drug Saf; 2011 Jul; 34(7):545-65. PubMed ID: 21663331
[TBL] [Abstract][Full Text] [Related]
19.
Cayzeele-Decherf A; Pélerin F; Leuillet S; Douillard B; Housez B; Cazaubiel M; Jacobson GK; Jüsten P; Desreumaux P
World J Gastroenterol; 2017 Jan; 23(2):336-344. PubMed ID: 28127207
[TBL] [Abstract][Full Text] [Related]
20. Treatment of abdominal pain in irritable bowel syndrome.
Vanuytsel T; Tack JF; Boeckxstaens GE
J Gastroenterol; 2014 Aug; 49(8):1193-205. PubMed ID: 24845149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
